Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2,617 $ 78,005,004 $ 636,886 $ (48,357,638) $ 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the financing, net of financing costs [1] $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (in Shares) [1] 2,564,000        
Offering costs allocated to warrant liabilities [1] 604,118 604,118
Warrants issued in connection with private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809        
Stock based compensation:          
Common stock $ 20 925,384 925,404
Common stock (in Shares) 197,790        
Options 1,092,399 1,092,399
Comprehensive income (loss):          
Net income (loss) (16,198,585) (16,198,585)
Other comprehensive income (loss) 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Balance at Dec. 31, 2021 $ 3,404 107,184,137 817,440 (68,682,286) 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925        
Shares issued for directors’ and professional fees $ 5 149,713 149,718
Shares issued for directors’ and professional fees (in Shares) 51,319        
Stock based compensation:          
Options 596,467 596,467
Comprehensive income (loss):          
Net income (loss) 1,563,713 1,563,713
Other comprehensive income (loss) (728,081) (728,081)
Balance at Mar. 31, 2022 $ 3,409 $ 107,930,317 $ 89,359 $ (67,118,573) $ 40,904,512
Balance (in Shares) at Mar. 31, 2022 34,087,244        
[1] Consists of $11,666,200 of gross proceeds from the February 2021 PIPE offering, net of placement agent fees and other cash offering costs of $968,930. Of the $968,930 of offering costs, $364,812 was allocated to the common stock and $604,118 was allocated to the warrant liabilities and expensed immediately due to their liability classification.